Sign inJoin waitlistJoin the waitlist

Mustafa Khasraw

Professor of Neurosurgery · Duke Department of Medicine

Credentials: · ·

History

Duke Department of Medicine
Present
Duke Department of Medicine
Present
Duke Department of Medicine
Present

Rijksuniversiteit Groningen
2001

Research

Management of glioblastoma: State of the art and future directions
Review · Current Anthropology · 2020 · Last of 6 authors · 1,727 citations
High tumor mutation burden fails to predict immune checkpoint blockade response across all cancer types
Annals of Oncology · 2021 · 855 citations
Radiotherapy combined with nivolumab or temozolomide for newly diagnosed glioblastoma with unmethylated MGMT promoter: An international randomized phase III trial
Neuro-Oncology · 2023 · 466 citations

David Ashley
35 papers
Amy Heimberger
17 papers
John de Groot
13 papers
John Sampson
13 papers
Manmeet Ahluwalia
12 papers
PW
Patrick Wen
12 papers
Peter Fecci
11 papers · 4 as a fellow
Evanthia Galanis
10 papers
Timothy Cloughesy
10 papers
Minesh Mehta
9 papers
Susan Chang
9 papers
Andrew Lassman
8 papers

Grants

6-Thio-2'-Deoxyguanosine: A Novel Immunogenic Telomerase-Mediated Therapy in Glioblastoma - A Duke and UTSW Collaboration
National Cancer Institute · U19
Contact PI · $2.3M · Duke University
2021–2027

Clinical trials

BRiTE - Bispecific T Cell Engager for Patients With Glioblastoma
Principal investigator · Recruiting · Phase 1
Mustafa Khasraw, MBChB, MD, FRCP, FRACP
2026–2027
A Window of Opportunity Study of Patritumab Deruxtecan in Patients With Brain Metastases
Principal investigator · Withdrawn · Phase 2
Mustafa Khasraw, MBChB, MD, FRCP, FRACP
2025–2027
A Multicenter Trial to Identify Optimal Atezolizumab Biomarkers in the Setting of Recurrent Glioblastoma. The MOAB Trial
Principal investigator · Recruiting · Phase 2
Duke University
2024–2028
ETAPA I: Peptide-based Tumor Associated Antigen Vaccine in GBM
Principal investigator · Active not recruiting · Phase 1
Mustafa Khasraw, MBChB, MD, FRCP, FRACP
2023–2028